Clinical Trials
23 trialsNCT04729387 2026-03-13
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
Novartis
Phase 3 Terminated
NCT05092360 2025-08-28
ARTISTRY-7
Mural Oncology, Inc
Phase 3 Terminated
NCT02470585 2024-10-26
VELIA
AbbVie
Phase 3 Terminated
NCT04849858 2024-08-23
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
University of California, Irvine
Phase 3 Terminated
NCT04460807 2024-02-12
EXPERT
Ente Ospedaliero Ospedali Galliera
Phase 3 Terminated
NCT04729608 2023-10-30
AXLerate-OC
Aravive, Inc.
Phase 3 Terminated
NCT05329545 2023-10-26
UP-NEXT
Mersana Therapeutics
Phase 3 Terminated
NCT03642132 2023-04-06
JAVELIN OVARIAN PARP100
Pfizer
Phase 3 Terminated
NCT00849667 2022-12-30
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Morphotek
Phase 3 Terminated
NCT01905592 2022-11-15
BRAVO
Tesaro, Inc.
Phase 3 Terminated
NCT03690739 2022-02-24
Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer
AGO Research GmbH
Phase 3 Terminated
NCT01170650 2021-09-30
PROCEED
Endocyte
Phase 3 Terminated
NCT02718417 2020-07-14
JAVELIN OVARIAN 100
Pfizer
Phase 3 Terminated
NCT01281254 2017-12-02
TRINOVA-2
Amgen
Phase 3 Terminated
NCT00324324 2017-05-09
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
OHSU Knight Cancer Institute
Phase 3 Terminated
NCT01493505 2017-02-23
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Amgen
Phase 3 Terminated
NCT01840943 2015-12-23
A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Xian-Janssen Pharmaceutical Ltd.
Phase 3 Terminated
NCT00350948 2013-11-27
ASSIST-5
Telik
Phase 3 Terminated
NCT00002819 2013-04-11
Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
GOG Foundation
Phase 3 Terminated
NCT00006356 2012-09-24
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00653952 2010-04-27
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3 Terminated
NCT00050375 2007-12-18
Clinical Trial for Ovarian Cancer (OvaRex®)
Unither Pharmaceuticals
Phase 3 Terminated
NCT00047632 2007-11-01
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
InterMune
Phase 3 Terminated